IGF2 and hepatocellular carcinoma: Experimental overexpression of miR-493-5p promoted an anti-cancer response by inhibiting HCC cell growth and invasion, in part, through the negative regulation of insulin-like growth factor 2 (IGF2) and the IGF2-derived intronic oncomir miR-483-3p.